以临床需求为导向的呼吸系统传染病基础研究

Prior use of ACEI and ARB does not affect COVID-19 clinical outcome

Surveillance and Early Warning of Respiratory Communicable Diseases

Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19

The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study

In Vitro and In Vivo Efficacy of Cefiderocol Plus Tigecycline, Colistin, or Meropenem against Carbapenem-Resistant Acinetobacter baumannii

Prognostic Risk Factors of carbapenem -resistance Gram-negative Bacteria Bloodstream Infection in Immunosuppressed Patients-a 7-year retrospective cohort study

Clinical and Microbiological Characteristics of Difficult-To-Treat Resistance Klebsiella pneumoniae infection

Mechanisms of eosinophilic asthma and targeted therapy

Comorbidity Profiles of Patients Hospitalized for an Asthma Exacerbation

The role of HSP90 in chronic lung diseases

Validation and optimization of COPD population screener questionnaire (COPD-PS) in Chinese population: A national multicenter study

Effect of inhaled corticosteroids on microbiome and microbial correlations in asthma over a nine-month period

Temporal trend in the burden of asthma and its attributed risk factors in China from 1990 to 2019, with a projection until 2030: comparison with South Korea, Japan and the World

IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Serum exosomal miR-1258: A novel biomarker for the diagnosis of acute exacerbations of COPD